BioNTech will present significant clinical trial data at the prestigious ASCO Annual Meeting, highlighting the advancement of its diversified oncology portfolio. The preliminary results for BNT327 and ...

Faculty in this hub lead the design, coordination, and analysis of clinical trials for cancer treatment, survivorship, vaccine efficacy, infectious disease prevention and treatment, and cancer ...

Zurich-based Rivia raises €13M to expand its agentic AI platform for biotech clinical trials, building on a €3M seed in 2024.

Presentation of preclinical data indicating the potential of regRNA-targeting to increase protein levels in a clinically meaningful way, highlighting the company's innovative approach to gene ...

Please provide your email address to receive an email when new articles are posted on . Use of decentralized elements in cancer clinical trials did not have long-term negative effects on data quality.

Single-trial approvals are raising the bar on trial design and execution. The new paradigm is pushing sponsors to plan ...

BioNTech has shown why it made small cell lung cancer (SCLC) a priority for its PD-L1xVEGF-A bispecific. The biotech linked BNT327 to a median overall survival (OS) of 16.8 months in a Chinese phase 2 ...

Biotech picks highlight cystic fibrosis drug trials, rare-disease therapies and upcoming regulatory catalysts as clinical data and approvals approach.

New research opens the door for more streamlined and patient-centric protocols, informed by benchmarking analysis of phase II and III protocol procedures The research assesses how protocol design ...

Modern clinical trials face an enrollment challenge. Over 80 percent of clinical trials conducted in the United States fail to meet their recruitment timelines, contributing to delays in therapeutic ...

Yvete Toivola, PhD, is the vice president of Product Development at Flywheel, where she leads the development of imaging-centered data platforms that support rigorous scientific and clinical research.